Qian Lei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qian Lei has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
- Juanjuan Lyu
Department of Pediatrics West China Second University Hospital, Sichuan University Chengdu China
5 shared publications Keli Huang
2 Department of Cardiac Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
5 shared publications- Panke Cheng
Institute of Cardiovascular Diseases & Department of Cardiology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China
5 shared publications Peng Qu
Institute of Cardiovascular Diseases, Department of Cardiology, Sichuan Provincial People’s Hospital, School of Medicine,University of Electronic Science and Technology of China, Chengdu, China
5 shared publications- Si Zeng
Department of Anesthesiology, School of Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, Sichuan, PR China.
5 shared publications Ruixuan Wang
Department of Anesthesiology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, People’s Republic of China
4 shared publications
Latest Publications
- Open Access
- 15 November 2026
- Published by Wiley in Journal of Diabetes
- Vol. 18 (11) , e70299
Role of Metabolism‐Coupled Protein Modification in Diabetic Cardiomyopathy
Diabetic cardiomyopathy (DCM) is a diabetes‐specific myocardial disorder, characterized by structural and functional abnormalities of the heart independent of coronary artery disease, hypertension, or valvular pathology. Metabolic abnormalities are now understood to play pivotal roles in DCM pathogenesis. Chronic hyperglycemia and insulin resistance disrupt cardiac energy metabolism, shifting myocardial substrate utilization from glucose to fatty acids. These metabolic disorders lead to imbalances in intracellular metabolite abundance, which, in turn, induce abnormalities in various biochemical reactions involving these metabolites, including post‐translational modifications (PTMs) of proteins. The strong correlation between metabolism and protein PTMs has led to the concept of metabolically coupled protein modifications (MCPMs). In this narrative review, we define strict MCPMs as PTMs that directly use metabolites as substrates, and we also discuss metabolism‐related PTMs such as phosphorylation and ROS/RNS‐mediated modifications. We summarize reported roles of MCPMs in DCM, distinguish evidence levels, and outline major issues for future research.
- 15 November 2026
- Published by Wiley in Journal of Diabetes
- Vol. 18 (11) , e70299
Open AccessRole of Metabolism‐Coupled Protein Modification in Diabetic Cardiomyopathy
Diabetic cardiomyopathy (DCM) is a diabetes‐specific myocardial disorder, characterized by structural and functional abnormalities of the heart independent of coronary artery disease, hypertension, or valvular pathology. Metabolic abnormalities are now understood to play pivotal roles in DCM pathogenesis. Chronic hyperglycemia and insulin resistance disrupt cardiac energy metabolism, shifting myocardial substrate utilization from glucose to fatty acids. These metabolic disorders lead to imbalances in intracellular metabolite abundance, which, in turn, induce abnormalities in various biochemical reactions involving these metabolites, including post‐translational modifications (PTMs) of proteins. The strong correlation between metabolism and protein PTMs has led to the concept of metabolically coupled protein modifications (MCPMs). In this narrative review, we define strict MCPMs as PTMs that directly use metabolites as substrates, and we also discuss metabolism‐related PTMs such as phosphorylation and ROS/RNS‐mediated modifications. We summarize reported roles of MCPMs in DCM, distinguish evidence levels, and outline major issues for future research.
- Open Access
- 18 August 2026
- Published by OAE Publishing Inc. in Vessel Plus
- Vol. 10
Pathological remodeling driven by the cardiac autoantigen-dendritic cell-CD4+ T-cell axis under sustained mechanical stress load
Pressure overload-induced cardiac remodeling is a shared pathological basis in the progression of hypertension, aortic stenosis, aortic coarctation, and related diseases, and represents an important antecedent stage in the development of heart failure. This process is not driven by a single injurious event, but evolves gradually from early compensatory hypertrophy to late decompensated remodeling. In the early phase, the heart can maintain short-term hemodynamic stability through cardiomyocyte hypertrophy, ventricular wall thickening, and a certain degree of contractile compensation. However, when abnormal loading persists, mechanical stretch, perfusion imbalance, and metabolic stress progressively accumulate, leading to a decline in the intrinsic adaptive capacity of cardiomyocytes. This is followed by ventricular structural rearrangement, reduced compliance, aggravated interstitial fibrosis, and impaired systolic and diastolic function. Thus, pressure overload-induced cardiac remodeling is not merely a mechanical adaptation, but a dynamic pathological process that progresses from limited compensation to sustained injury and functional imbalance. Recent studies have shown that the progression of this disease process cannot be explained solely by hemodynamic burden, as immune responses are also involved. The chronically overloaded myocardium is not a passive recipient of stress. Rather, under sustained stress, it continuously releases danger signals, reshapes the local inflammatory milieu, and increases the likelihood that cardiac components will be recognized by the immune system. Therefore, immune involvement is not simply a secondary phenomenon following pressure overload, but an important factor that drives the transition from compensation to decompensation. Compared with acute and transient inflammatory responses, a more critical issue is whether local injury signals can be converted into a sustained adaptive immune response, because this step determines whether remodeling evolves from a relatively confined tissue reaction into a persistent chronic pathological process.
- 18 August 2026
- Published by OAE Publishing Inc. in Vessel Plus
- Vol. 10
Open AccessPathological remodeling driven by the cardiac autoantigen-dendritic cell-CD4+ T-cell axis under sustained mechanical stress load
Pressure overload-induced cardiac remodeling is a shared pathological basis in the progression of hypertension, aortic stenosis, aortic coarctation, and related diseases, and represents an important antecedent stage in the development of heart failure. This process is not driven by a single injurious event, but evolves gradually from early compensatory hypertrophy to late decompensated remodeling. In the early phase, the heart can maintain short-term hemodynamic stability through cardiomyocyte hypertrophy, ventricular wall thickening, and a certain degree of contractile compensation. However, when abnormal loading persists, mechanical stretch, perfusion imbalance, and metabolic stress progressively accumulate, leading to a decline in the intrinsic adaptive capacity of cardiomyocytes. This is followed by ventricular structural rearrangement, reduced compliance, aggravated interstitial fibrosis, and impaired systolic and diastolic function. Thus, pressure overload-induced cardiac remodeling is not merely a mechanical adaptation, but a dynamic pathological process that progresses from limited compensation to sustained injury and functional imbalance. Recent studies have shown that the progression of this disease process cannot be explained solely by hemodynamic burden, as immune responses are also involved. The chronically overloaded myocardium is not a passive recipient of stress. Rather, under sustained stress, it continuously releases danger signals, reshapes the local inflammatory milieu, and increases the likelihood that cardiac components will be recognized by the immune system. Therefore, immune involvement is not simply a secondary phenomenon following pressure overload, but an important factor that drives the transition from compensation to decompensation. Compared with acute and transient inflammatory responses, a more critical issue is whether local injury signals can be converted into a sustained adaptive immune response, because this step determines whether remodeling evolves from a relatively confined tissue reaction into a persistent chronic pathological process.
- Open Access
- 27 July 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (11) , 14695-14704
Effect of dezocine combined with sufentanil on postoperative recovery quality and analgesia in patients undergoing laparoscopic thoracic surgery: the EZGO multicenter randomized double-blind parallel controlled trial
Background: Dezocine has been used for postoperative analgesia. However, its combination with sufentanil on postoperative recovery quality remains poorly understood. Methods: The Ease Go multicenter randomized controlled trial recruited 210 patients undergoing laparoscopic thoracic surgery from eight tertiary academic medical centers. The dezocine–sufentanil group received dezocine 1.0 mg/kg combined with sufentanil 2.0 μg/kg, while the sufentanil monotherapy group received sufentanil 3.0 μg/kg via a patient-controlled intravenous analgesia (PCIA) pump. The primary outcome was the quality of recovery (QoR-15) at 24 hours after PCIA pump initiation. The secondary outcomes included qualified recovery quality, patient global impression of change, the effective number of analgesic pump compressions, postoperative pain scores, as well as the use of rescue analgesics within 48 hours after PCIA pump initiation. Results: The mean QoR-15 scores at 24 and 48 hours after PCIA pump initiation in the dezocine–sufentanil vs. sufentanil group were 111.16 vs. 108.12 ( P = 0.321) and 121.96 vs. 120.14 ( P = 0.501), respectively. A higher proportion of qualified recovery quality was observed in the dezocine–sufentanil group (71.72% vs. 57.00%, P = 0.030 at 24 hours; 78.79% vs. 63.00%, P = 0.014 at 48 hours). The pain score was significantly lower in the dezocine–sufentanil group compared to the sufentanil group at 2, 4, 6, and 12 hours after PCIA pump initiation (all P < 0.05). The effective number of analgesic pump compressions (6.54 vs. 11.85, P = 0.001) and the proportion of patients requiring rescue medication (18.18% vs. 32.00%, P = 0.025) within 48 hours after pump initiation were both lower in the dezocine–sufentanil group. Conclusions: The QoR-15 score after laparoscopic thoracic surgery was not improved by the combined analgesia with dezocine and sufentanil. Nevertheless, the combined analgesia provided a higher qualified recovery quality rate and fewer analgesic requirements than sufentanil analgesia.
- 27 July 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (11) , 14695-14704
Open AccessEffect of dezocine combined with sufentanil on postoperative recovery quality and analgesia in patients undergoing laparoscopic thoracic surgery: the EZGO multicenter randomized double-blind parallel controlled trial
Background: Dezocine has been used for postoperative analgesia. However, its combination with sufentanil on postoperative recovery quality remains poorly understood. Methods: The Ease Go multicenter randomized controlled trial recruited 210 patients undergoing laparoscopic thoracic surgery from eight tertiary academic medical centers. The dezocine–sufentanil group received dezocine 1.0 mg/kg combined with sufentanil 2.0 μg/kg, while the sufentanil monotherapy group received sufentanil 3.0 μg/kg via a patient-controlled intravenous analgesia (PCIA) pump. The primary outcome was the quality of recovery (QoR-15) at 24 hours after PCIA pump initiation. The secondary outcomes included qualified recovery quality, patient global impression of change, the effective number of analgesic pump compressions, postoperative pain scores, as well as the use of rescue analgesics within 48 hours after PCIA pump initiation. Results: The mean QoR-15 scores at 24 and 48 hours after PCIA pump initiation in the dezocine–sufentanil vs. sufentanil group were 111.16 vs. 108.12 ( P = 0.321) and 121.96 vs. 120.14 ( P = 0.501), respectively. A higher proportion of qualified recovery quality was observed in the dezocine–sufentanil group (71.72% vs. 57.00%, P = 0.030 at 24 hours; 78.79% vs. 63.00%, P = 0.014 at 48 hours). The pain score was significantly lower in the dezocine–sufentanil group compared to the sufentanil group at 2, 4, 6, and 12 hours after PCIA pump initiation (all P < 0.05). The effective number of analgesic pump compressions (6.54 vs. 11.85, P = 0.001) and the proportion of patients requiring rescue medication (18.18% vs. 32.00%, P = 0.025) within 48 hours after pump initiation were both lower in the dezocine–sufentanil group. Conclusions: The QoR-15 score after laparoscopic thoracic surgery was not improved by the combined analgesia with dezocine and sufentanil. Nevertheless, the combined analgesia provided a higher qualified recovery quality rate and fewer analgesic requirements than sufentanil analgesia.
- Open Access
- 1 June 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-24
High-Altitude Hypoxic Preconditioning Attenuates Lipopolysaccharide-Induced Lung Injury and is Associated with Alveolar-Capillary Barrier Maintenance
Introduction: High-altitude hypoxic preconditioning (HAP) is an adaptive state induced by sustained exposure to hypobaric hypoxia. In addition to improving tolerance to hypoxia itself, HAP may also modify organ responses to subsequent inflammatory stress. The alveolar-capillary barrier is essential for maintaining pulmonary structural integrity, fluid balance, and gas exchange, and its disruption is a central event in inflammatory lung injury. However, whether HAP-related pulmonary protection is associated with preservation of the alveolar-capillary barrier and coordinated changes in barrier-related cells remains unclear. This study aimed to investigate the effects of HAP on alveolar-capillary barrier preservation under lipopolysaccharide (LPS) challenge and to explore the associated cellular transcriptional characteristics. Methods: A rat model of HAP was established by exposure to hypobaric hypoxia for 4 weeks. Rats were assigned to four groups: normoxic control (C), normoxia+LPS (CL), HAP control (H), and HAP+LPS (HL). Gross lung appearance, lung dry/wet ratio, histopathology, inflammatory and oxidative stress markers, and arterial blood gas parameters were evaluated. Single-cell RNA sequencing was performed in the CL and HL groups to assess transcriptional changes in endothelial cells, epithelial cells, and macrophages. Transmission electron microscopy and immunofluorescence staining for VE-cadherin and E-cadherin were used to evaluate barrier ultrastructure and junctional integrity. Results: Compared with the CL group, the HL group showed reduced pulmonary edema, less exudation and congestion, milder histological damage, and better oxygenation under LPS challenge. Lactate elevation was attenuated and metabolic changes were less pronounced in the HL group. Single-cell transcriptomic analysis showed distinct transcriptional characteristics in barrier-related cells after HAP. Endothelial cells in the HL group exhibited increased expression of genes related to cell junctions and cytoskeletal organization, epithelial cells exhibited upregulated expression of genes associated with cell membrane structure, cell adhesion, and alveolar fluid clearance, accompanied by an increased proportion of AT1 cells and a decreased proportion of tuft cells. Macrophages tended to express more repair-related genes. In contrast, the CL group showed more stress-, injury-, inflammation-, and interferon-related transcriptional features. Ultrastructural examination demonstrated better preservation of endothelial and alveolar epithelial integrity in the HL group. Immunofluorescence analysis further showed stronger and more continuous VE-cadherin and E-cadherin signals in the HL group than in the CL group. Conclusion: HAP was associated with better preservation of the alveolar-capillary barrier under LPS challenge, as reflected by reduced pulmonary edema, improved oxygenation, stronger junctional protein signals, and better preserved barrier structure. This barrier-protective effect was accompanied by coordinated transcriptional changes in endothelial cells, epithelial cells, and macrophages. After HAP, endothelial cells undergo characteristic phenotypic transformation and exhibit enhanced intercellular adhesive junctions. Epithelial cells present increased AT1 cells and decreased Tuft cells, with strengthened intercellular adhesive junctions. Macrophages display alterations in functional status. These changes help maintain the structural integrity of the alveolar-capillary barrier and further mitigate LPS-induced acute lung injury, which is characterized by improved oxygenation, reduced exudation, and a lower magnitude of lactate elevation.Schematic illustrating HAP-driven pulmonary cellular adaptive remodeling to alleviate LPS-induced acute lung injury.
- 1 June 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-24
Open AccessHigh-Altitude Hypoxic Preconditioning Attenuates Lipopolysaccharide-Induced Lung Injury and is Associated with Alveolar-Capillary Barrier Maintenance
Introduction: High-altitude hypoxic preconditioning (HAP) is an adaptive state induced by sustained exposure to hypobaric hypoxia. In addition to improving tolerance to hypoxia itself, HAP may also modify organ responses to subsequent inflammatory stress. The alveolar-capillary barrier is essential for maintaining pulmonary structural integrity, fluid balance, and gas exchange, and its disruption is a central event in inflammatory lung injury. However, whether HAP-related pulmonary protection is associated with preservation of the alveolar-capillary barrier and coordinated changes in barrier-related cells remains unclear. This study aimed to investigate the effects of HAP on alveolar-capillary barrier preservation under lipopolysaccharide (LPS) challenge and to explore the associated cellular transcriptional characteristics. Methods: A rat model of HAP was established by exposure to hypobaric hypoxia for 4 weeks. Rats were assigned to four groups: normoxic control (C), normoxia+LPS (CL), HAP control (H), and HAP+LPS (HL). Gross lung appearance, lung dry/wet ratio, histopathology, inflammatory and oxidative stress markers, and arterial blood gas parameters were evaluated. Single-cell RNA sequencing was performed in the CL and HL groups to assess transcriptional changes in endothelial cells, epithelial cells, and macrophages. Transmission electron microscopy and immunofluorescence staining for VE-cadherin and E-cadherin were used to evaluate barrier ultrastructure and junctional integrity. Results: Compared with the CL group, the HL group showed reduced pulmonary edema, less exudation and congestion, milder histological damage, and better oxygenation under LPS challenge. Lactate elevation was attenuated and metabolic changes were less pronounced in the HL group. Single-cell transcriptomic analysis showed distinct transcriptional characteristics in barrier-related cells after HAP. Endothelial cells in the HL group exhibited increased expression of genes related to cell junctions and cytoskeletal organization, epithelial cells exhibited upregulated expression of genes associated with cell membrane structure, cell adhesion, and alveolar fluid clearance, accompanied by an increased proportion of AT1 cells and a decreased proportion of tuft cells. Macrophages tended to express more repair-related genes. In contrast, the CL group showed more stress-, injury-, inflammation-, and interferon-related transcriptional features. Ultrastructural examination demonstrated better preservation of endothelial and alveolar epithelial integrity in the HL group. Immunofluorescence analysis further showed stronger and more continuous VE-cadherin and E-cadherin signals in the HL group than in the CL group. Conclusion: HAP was associated with better preservation of the alveolar-capillary barrier under LPS challenge, as reflected by reduced pulmonary edema, improved oxygenation, stronger junctional protein signals, and better preserved barrier structure. This barrier-protective effect was accompanied by coordinated transcriptional changes in endothelial cells, epithelial cells, and macrophages. After HAP, endothelial cells undergo characteristic phenotypic transformation and exhibit enhanced intercellular adhesive junctions. Epithelial cells present increased AT1 cells and decreased Tuft cells, with strengthened intercellular adhesive junctions. Macrophages display alterations in functional status. These changes help maintain the structural integrity of the alveolar-capillary barrier and further mitigate LPS-induced acute lung injury, which is characterized by improved oxygenation, reduced exudation, and a lower magnitude of lactate elevation.Schematic illustrating HAP-driven pulmonary cellular adaptive remodeling to alleviate LPS-induced acute lung injury.
- Open Access
- 25 May 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1762740
Application of an artificial-intelligence–based transesophageal echocardiography simulation system in residency training
Background: Transesophageal echocardiography (TEE) is a key perioperative monitoring modality in anesthesiology, but traditional training is constrained by limited case exposure, patient safety concerns, and heterogeneous learning curves. Artificial-intelligence (AI)–based TEE simulators that integrate 3-dimensional (3D) anatomy visualization, interactive image interpretation, and virtual probe manipulation may improve learning efficiency and confidence in residents. Methods: In this single-center randomized controlled study, sixty anesthesiology residents in standardized training at Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (December 2024–December 2025) were randomly allocated to an AI group ( n = 30) or a control group ( n = 30). Both groups received the same instructor-led TEE curriculum. The control group underwent traditional teaching (lectures, static images, and video demonstrations), whereas the AI group additionally trained on an AI-based TEE simulation system that provided 3D anatomy visualization, interactive image-reading exercises, and virtual probe operation with real-time feedback. Outcomes included a standardized image-interpretation test (0–100), Objective Structured Assessment of Technical Skills for TEE (OSATS-TEE; 0–150), key-view acquisition rate, procedure time, self-efficacy score, and course satisfaction (all 0–100). Results: Baseline demographic characteristics did not differ between groups (all p > 0.05). After the course, the AI group achieved higher image-interpretation test scores than the control group (84.3 ± 6.9 vs. 78.1 ± 7.8, p = 0.002) and higher scores on the training-context-specific OSATS-TEE assessment (121.5 ± 9.2 vs. 112.4 ± 10.1, p < 0.001). The key-view acquisition rate was significantly higher in the AI group (88.2% ± 8.1% vs. 76.5% ± 9.7%, p < 0.001), while mean operation time was shorter (27.1 ± 3.9 min vs. 32.4 ± 4.6 min, p < 0.001). Self-efficacy (87.2 ± 7.5 vs. 78.3 ± 8.4, p < 0.001) and course satisfaction (91.0 ± 6.8 vs. 80.5 ± 7.6, p < 0.001) were also higher in the AI group. Conclusions: An AI-based TEE simulation training system was associated with improved residents' simulation-based TEE learning outcomes, including image-interpretation performance, procedural assessment scores, efficiency, and perceived self-efficacy, compared with traditional teaching. However, further studies are needed to determine whether these gains translate into clinical performance in perioperative practice.
- 25 May 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1762740
Open AccessApplication of an artificial-intelligence–based transesophageal echocardiography simulation system in residency training
Background: Transesophageal echocardiography (TEE) is a key perioperative monitoring modality in anesthesiology, but traditional training is constrained by limited case exposure, patient safety concerns, and heterogeneous learning curves. Artificial-intelligence (AI)–based TEE simulators that integrate 3-dimensional (3D) anatomy visualization, interactive image interpretation, and virtual probe manipulation may improve learning efficiency and confidence in residents. Methods: In this single-center randomized controlled study, sixty anesthesiology residents in standardized training at Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (December 2024–December 2025) were randomly allocated to an AI group ( n = 30) or a control group ( n = 30). Both groups received the same instructor-led TEE curriculum. The control group underwent traditional teaching (lectures, static images, and video demonstrations), whereas the AI group additionally trained on an AI-based TEE simulation system that provided 3D anatomy visualization, interactive image-reading exercises, and virtual probe operation with real-time feedback. Outcomes included a standardized image-interpretation test (0–100), Objective Structured Assessment of Technical Skills for TEE (OSATS-TEE; 0–150), key-view acquisition rate, procedure time, self-efficacy score, and course satisfaction (all 0–100). Results: Baseline demographic characteristics did not differ between groups (all p > 0.05). After the course, the AI group achieved higher image-interpretation test scores than the control group (84.3 ± 6.9 vs. 78.1 ± 7.8, p = 0.002) and higher scores on the training-context-specific OSATS-TEE assessment (121.5 ± 9.2 vs. 112.4 ± 10.1, p < 0.001). The key-view acquisition rate was significantly higher in the AI group (88.2% ± 8.1% vs. 76.5% ± 9.7%, p < 0.001), while mean operation time was shorter (27.1 ± 3.9 min vs. 32.4 ± 4.6 min, p < 0.001). Self-efficacy (87.2 ± 7.5 vs. 78.3 ± 8.4, p < 0.001) and course satisfaction (91.0 ± 6.8 vs. 80.5 ± 7.6, p < 0.001) were also higher in the AI group. Conclusions: An AI-based TEE simulation training system was associated with improved residents' simulation-based TEE learning outcomes, including image-interpretation performance, procedural assessment scores, efficiency, and perceived self-efficacy, compared with traditional teaching. However, further studies are needed to determine whether these gains translate into clinical performance in perioperative practice.
- Open Access
- 29 April 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1807444
Serum metabolomics identifies GPC depletion in hepatic encephalopathy and its therapeutic potential for cognitive impairment
Background: Hepatic encephalopathy (HE), a common neurological complication in end-stage cirrhosis, is a complex disorder whose molecular pathogenesis has yet to be fully elucidated. Metabolomics studies provide novel insights into elucidating the pathological mechanisms of HE. This study aims to screen serum differential metabolites in cirrhosis and HE patients using metabolomics technology, with particular focus on validating the therapeutic effects of key metabolites on HE-associated cognitive dysfunction and its underlying mechanisms. Methods: This study was designed to first enroll 20–30 subjects per group (including healthy controls, cirrhosis patients, and HE patients) for serum untargeted metabolomic analysis using liquid chromatography-tandem mass spectrometry technology, combined with multivariate statistical analysis and pathway enrichment methods to identify key metabolites. This study established five experimental rat groups and developed a HE rat model via modified common bile duct ligation to evaluate the effects of key metabolite supplementation on cognitive function, while simultaneously assessing therapeutic outcomes through histopathological examination and ultrastructural observations. Results: A total of 2,375 metabolites were identified by metabolomic analysis. Comprehensive analysis screened five differentially expressed metabolites (including sn-glycero-3-phosphocholine (GPC)) significantly associated with disease progression, with GPC prioritized for subsequent validation of its effects on cognitive function in HE. The results demonstrated that GPC supplementation notably improved HE rats’ spatial working memory and motor ability, while alleviating hepatic inflammatory infiltration and blood-brain barrier damage. Conclusion: This study is the first to discover and confirm the protective effect of GPC in improving cognitive dysfunction in HE, and the mechanism may be related to preserving the integrity of the blood-brain barrier.
- 29 April 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1807444
Open AccessSerum metabolomics identifies GPC depletion in hepatic encephalopathy and its therapeutic potential for cognitive impairment
Background: Hepatic encephalopathy (HE), a common neurological complication in end-stage cirrhosis, is a complex disorder whose molecular pathogenesis has yet to be fully elucidated. Metabolomics studies provide novel insights into elucidating the pathological mechanisms of HE. This study aims to screen serum differential metabolites in cirrhosis and HE patients using metabolomics technology, with particular focus on validating the therapeutic effects of key metabolites on HE-associated cognitive dysfunction and its underlying mechanisms. Methods: This study was designed to first enroll 20–30 subjects per group (including healthy controls, cirrhosis patients, and HE patients) for serum untargeted metabolomic analysis using liquid chromatography-tandem mass spectrometry technology, combined with multivariate statistical analysis and pathway enrichment methods to identify key metabolites. This study established five experimental rat groups and developed a HE rat model via modified common bile duct ligation to evaluate the effects of key metabolite supplementation on cognitive function, while simultaneously assessing therapeutic outcomes through histopathological examination and ultrastructural observations. Results: A total of 2,375 metabolites were identified by metabolomic analysis. Comprehensive analysis screened five differentially expressed metabolites (including sn-glycero-3-phosphocholine (GPC)) significantly associated with disease progression, with GPC prioritized for subsequent validation of its effects on cognitive function in HE. The results demonstrated that GPC supplementation notably improved HE rats’ spatial working memory and motor ability, while alleviating hepatic inflammatory infiltration and blood-brain barrier damage. Conclusion: This study is the first to discover and confirm the protective effect of GPC in improving cognitive dysfunction in HE, and the mechanism may be related to preserving the integrity of the blood-brain barrier.
- Open Access
- 27 April 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (18)
Physiological super-resolution in situ recording reveals kinetic changes of sympathetic norepinephrine release in heart failure
Norepinephrine (NE) in the peripheral nervous system plays crucial roles in regulating peripheral organs in health and disease. However, the spatiotemporal dynamics of sympathetic NE release and its underlying mechanisms remain poorly characterized due to technical challenges. Here, we developed and validated a Slice ElectroChemistry (SEC) method to record sympathetic NE release in heart slices with combined super-resolution and high sensitivity at 1 μm × 1 ms × 1 nM as in patch-clamp recordings. By using the SEC method, we revealed the increased NE release, impaired NE reuptake, increased releasable NE-vesicle pool, and impaired vesicle recycling of sympathetic nerves in the heart of transverse aortic constriction-induced heart failure (HF) mouse model, and defined the increased expression of Cav2.2 calcium channel as a central mechanism mediating the facilitation of NE release and thus the pathogenesis of HF, clarifying a longstanding puzzle about the kinetic changes of cardiac sympathetic NE release in HF. Beyond the heart, SEC enables NE release recording in other peripheral organs and human tissues, providing a robust toolset to investigate sympathetic NE dynamics across diverse pathophysiological conditions.
- 27 April 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (18)
Open AccessPhysiological super-resolution in situ recording reveals kinetic changes of sympathetic norepinephrine release in heart failure
Norepinephrine (NE) in the peripheral nervous system plays crucial roles in regulating peripheral organs in health and disease. However, the spatiotemporal dynamics of sympathetic NE release and its underlying mechanisms remain poorly characterized due to technical challenges. Here, we developed and validated a Slice ElectroChemistry (SEC) method to record sympathetic NE release in heart slices with combined super-resolution and high sensitivity at 1 μm × 1 ms × 1 nM as in patch-clamp recordings. By using the SEC method, we revealed the increased NE release, impaired NE reuptake, increased releasable NE-vesicle pool, and impaired vesicle recycling of sympathetic nerves in the heart of transverse aortic constriction-induced heart failure (HF) mouse model, and defined the increased expression of Cav2.2 calcium channel as a central mechanism mediating the facilitation of NE release and thus the pathogenesis of HF, clarifying a longstanding puzzle about the kinetic changes of cardiac sympathetic NE release in HF. Beyond the heart, SEC enables NE release recording in other peripheral organs and human tissues, providing a robust toolset to investigate sympathetic NE dynamics across diverse pathophysiological conditions.
- Open Access
- 11 March 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1726522
The tryptophan-kynurenine pathway in cardiovascular diseases: mechanistic insights and therapeutic opportunities
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, making them crucial to further explore their mechanisms. Beyond traditional risk factors, disturbances in tryptophan metabolism, particularly the imbalance in the kynurenine pathway (KP) which accounts for over 95% of metabolic flux—have garnered significant attention in cardiovascular research. In the human body, tryptophan is primarily metabolized through the KP. This process is catalyzed by key enzymes, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase, which convert tryptophan into kynurenine and further downstream metabolites such as kynurenic acid and 3-hydroxykynurenine. Studies have shown that levels of multiple key metabolites in KP are dysregulated in patients with CVDs, and by participating in processes such as immune activation, inflammatory responses, reactive oxygen species production, and endothelial dysfunction, and they play a complex role in mediating the pathophysiology of various CVDs, including heart failure, atherosclerosis, and hypertension. This review will systematically outline the physiology of tryptophan metabolism and the KP, summarize how key enzymes and metabolites regulate CVDs, and explore their potential as novel biomarkers for early diagnosis and prognosis and as therapeutic targets. Additionally, the review will discuss the future applications of metabolomics and artificial intelligence in the diagnosis of CVDs and the development of new therapeutics, aiming to provide new perspectives for the prevention and treatment of CVDs.
- 11 March 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1726522
Open AccessThe tryptophan-kynurenine pathway in cardiovascular diseases: mechanistic insights and therapeutic opportunities
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, making them crucial to further explore their mechanisms. Beyond traditional risk factors, disturbances in tryptophan metabolism, particularly the imbalance in the kynurenine pathway (KP) which accounts for over 95% of metabolic flux—have garnered significant attention in cardiovascular research. In the human body, tryptophan is primarily metabolized through the KP. This process is catalyzed by key enzymes, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase, which convert tryptophan into kynurenine and further downstream metabolites such as kynurenic acid and 3-hydroxykynurenine. Studies have shown that levels of multiple key metabolites in KP are dysregulated in patients with CVDs, and by participating in processes such as immune activation, inflammatory responses, reactive oxygen species production, and endothelial dysfunction, and they play a complex role in mediating the pathophysiology of various CVDs, including heart failure, atherosclerosis, and hypertension. This review will systematically outline the physiology of tryptophan metabolism and the KP, summarize how key enzymes and metabolites regulate CVDs, and explore their potential as novel biomarkers for early diagnosis and prognosis and as therapeutic targets. Additionally, the review will discuss the future applications of metabolomics and artificial intelligence in the diagnosis of CVDs and the development of new therapeutics, aiming to provide new perspectives for the prevention and treatment of CVDs.
- Open Access
- 23 February 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1)
Lactate regulation in high-altitude hypoxic adaptation attenuates LPS-Induced acute lung injury: links to glucose metabolism and anti-inflammatory therapeutic potential
- 23 February 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1)
Open AccessLactate regulation in high-altitude hypoxic adaptation attenuates LPS-Induced acute lung injury: links to glucose metabolism and anti-inflammatory therapeutic potential